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Abstract
The increase of infections caused by resistant bacteria has become one of the
major health-care problems worldwide. The creation of multidisciplinary teams ded-
icated to the implementation of antimicrobial stewardship programmes (ASPs) is
encouraged by all clinical institutions to cope with this problem. In this chapter, we
describe the Wise Antimicrobial Stewardship Program Support System (WASPSS), a
CDSS focused on providing support for ASP teams. WASPSS gathers the required
information from other hospital systems in order to provide decision support in
antimicrobial stewardship from both patient-centered and global perspectives. To
achieve this, it combines business intelligence techniques with a rule-based inference
engine to integrate the data and knowledge required in this scenario. The system
provides functions such as alerts, recommendations, antimicrobial prescription sup-
port and global surveillance. Furthermore, it includes experimental modules for
improving the adoption of clinical guidelines and applying prediction models related
with antimicrobial resistance. All these functionalities are provided through a multi-
user web interface, personalized for each role of the ASP team.
Keywords: antimicrobial stewardship, antimicrobial resistance, infection
management, rule-based systems, data and knowledge integration, clinical practice
guidelines
1. Introduction
Antibiotics have been one of the most significant discoveries in medicine, to the
point that some researches talk about pre-antibiotic and post-antibiotic eras in
clinical practice due to their repercussion in the treatment of infectious diseases [1].
However, bacteria are able to develop resistance against antibiotics when they are
exposed to them for a long period of time. Indeed, in a short time after the wide-
spread usage of a novel antibiotic, new strains of bacteria resistant to it have
appeared [2]. The problem is so severe that international health organizations claim
that “... a post-antibiotic era -in which common infections and minor injures can
kill- is a very real possibility for the 21st century” [3].
It has been recognized by global health organizations that one of the main causes
of this problem, also known as antimicrobial resistance, is the overuse of antibiotics.
For this reason, they are encouraging the adoption of antimicrobial stewardship
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programmes (ASPs) [4–7], in order to develop specific actuations and protocols to
improve the antimicrobial usage and limit the rise of antimicrobial resistance. These
programs include recommendations about all the actions related to the use of
antimicrobials in clinical practice, such as the appropriateness of a particular anti-
biotic for an infection, its dosage, the route of administration or the duration of the
therapy [4].
Due to the complexity of this problem, one of the recommendations for the
hospital setting is to constitute a multidisciplinary team, called the antimicrobial
stewardship programme team (ASP team). This team should be composed of special-
ists from different clinical areas such as physicians, epidemiologists, pharmacists,
microbiologists and managers. The coordination of efforts obtained thanks to the
diversity of the ASP team members is seen as fundamental in order to achieve an
improvement in the rational use of antimicrobials within the institution.
First experiences in the implementation of ASP teams have obtained limited but
satisfactory results regarding the usage of antimicrobials [8, 9]. A well-known
disadvantage of the ASP methodology is the amount of time required by ASP
members to review alerts and documentation [10]. Therefore, these studies also
state the need for computerized tools to help with these complex tasks. The use of
clinical decision support systems (CDSSs) can be a key factor in improving the
results of ASP teams, taking into account the multi-user perspective of the problem,
the need for data and knowledge integration from different sources, and the
requirement to provide support both for a particular patient and for the whole
institution in a coordinated manner. In this chapter, we perform an overview of
different studies related with decision support in antimicrobial resistance and per-
form a detailed description of theWise Antimicrobial Stewardship Program Support
System (WASPSS), a CDSS focused on ASP teams.
2. Decision support in the context of antimicrobial resistance
Infectious diseases were one of first clinical topics related with decision support
systems. One of these first systems was MYCIN [11], which relied on production
rules derived from discussions with clinical experts to provide suggestions about the
diagnosis and appropriate management of infected patients. Although the system
was never used clinically, it was a relevant reference for the research and develop-
ment of CDSSs during the 1980s [12].
Another relevant work was the HELP system [13], which provided alerts,
reports and suggestions obtained from the data available in clinical records. With
additional epidemiologic data and expert knowledge, it was used to provide recom-
mendations about antibiotic treatments and therapies [14].
The infections acquired within clinical institutions (i.e., nosocomial infections)
are commonly caused by bacteria resistant to antibiotics and, therefore, harder to
treat. The relevance of these infections led researchers to focus on this problem. The
GermWatcher expert system [15, 16] is capable of evaluating the results of cultures
with the aim of detecting nosocomial infections. GermWatcher uses a rule engine
whose knowledge base is based on the guidelines of the Nosocomial Infection
Surveillance System from the Centers for Disease Control. Thanks to them, it is
capable of classifying the alert level of a microorganism and deciding whether or not
to report it as a nosocomial infection.
The Mercurio system [17] is also focused on the detection and monitoring
of nosocomial infections. It was intended for different kinds of users, such as
laboratory physicians, clinicians and epidemiologists, and included knowledge
from several sources, such as antibiotic hierarchical definitions and international
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guidelines for microbiological laboratories. It is capable of checking the
susceptibility tests in order to ensure that they have been performed according to
the guidelines, differentiating among possible strains of bacteria, and warning
about possible outbreaks of a particular strain. Furthermore, association rules are
used to identify local resistance patterns that are not covered by the standard
guidelines.
Another example focused on this problem is the HASIS information system [18]
that implements the guidelines for hospital-acquired infections published by the
Centers for Disease Control and Prevention and includes algorithms for the detec-
tion of suspicious cases. It employs a service-oriented architecture as a basis on
which to integrate the surveillance data required for this task.
However, the rise and spread of multidrug-resistant bacteria has forced the
research community to tackle the problem of nosocomial infections from the
broader perspective of antimicrobial stewardship.
The DebugIT (Detecting and Eliminating Bacteria UsinG Information Technology)
European project [19] was developed to gather information about antimicrobial
resistance from heterogeneous sources [20]. It uses semantic web technologies to
structure data and is capable of performing data analysis on it in order to provide
decision support [21].
From yet another point of view, the TREAT system [22] uses causal probabilistic
networks to propose an antibiotic treatment when the infectious agent is still
unknown, based on the local epidemiological data and clinical observations such as
the site of infection, symptoms and background disorders. This signifies that the
spectrum of the treatments can be narrower, and less antimicrobial resistance is,
therefore, developed.
Other proposals are focused on intensive care units (ICUs), since they are the
hospital wards with the highest number of nosocomial infections and multi-
resistant bacteria.
For example, the objective of the MoniICU system [23] is to identify and mon-
itor nosocomial infections in ICUs. It uses production rules defined by using
ARDEN syntax, an HL7 standard oriented toward sharing medical knowledge.
Furthermore, it includes a fuzzy abstraction module for the definition of nosoco-
mial infections.
Another example is the COSARA platform [24], which is focused on infection
surveillance in ICUs. It provides functionalities for the automatic integration of
clinical data and clinical decision support and alerts to alarming trends, among
others.
Recently, some relevant works have been finally focused on supporting ASP
teams in order to assess in the use of antibiotics by hospitals. The Antimicrobial
Prescription Surveillance System [25] is focused on identifying potentially inappro-
priate antimicrobial prescriptions and reporting them to pharmacists. It has a
knowledge base with contraindications regarding drug–drug interactions, drug-bug
mismatches and maximum daily dose, among others. Furthermore, the system
includes a learning algorithm with which to evaluate the feedback regarding the
launched alerts and reduce the number of those that are erroneous or clinically
irrelevant.
In Evans et al. [26], a framework of medical informatics tools is proposed in
order to provide ASP teams with support. It automatically generates spreadsheets
containing the antibiotics that are used daily and the parameters available to decide
the antimicrobial therapy for specific patients. It additionally sends e-mail and SMS
alerts to ASP members when timely-critical laboratory results are available, such as
positive blood or cerebrospinal fluid cultures. Finally, it generates different reports
based on the National Healthcare Safety Network specifications.
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The HAITooL system [27] is also focused on ASP teams. It monitors antibiotic
usage, rates antibiotic-resistant bacteria and allows early identification of outbreaks.
It integrates evidence-based algorithms with which to support proper antibiotic
prescription.
And a final example is the Wise Antimicrobial Stewardship Program Support
System (WASPSS) [10]. WASPSS is focused on ASP team support and gathers
information for multiple hospital information systems in order to provide a unified
decision support for typical ASP tasks. It is the CDSS explained in detail in this
chapter.
3. The WASPSS project
The University Hospital of Getafe (UHG) is a medium-size hospital (approxi-
mately 450 beds), which is located in Madrid, Spain. It has units covering most
medical specialities, including a burns unit, although there are no cardiac surgery or
transplant units. In 2014, the UHG set up an antibiotic stewardship programme
denominated as “program for the multidisciplinary care in the assessment and
control of the antimicrobial therapy” (PAMACTA) [10]. The PAMACTA team is
composed of members from different specialities, including pharmacists, microbi-
ologists, surgeons, internists, intensivists and infection preventionists. This team
has been formed to address two organizational proposals: (a) to include a represen-
tative of each hospital service, or at least those services with a higher use of antibi-
otics, and (b) to involve all the physicians as part of the ASP. The intention of these
two proposals is to reduce the time spent on distributing the task among depart-
ments and the integration of individual clinical expertise with the best available
external clinical evidence, a basic principle of evidence-based medicine [28].
TheWise Antibiotic Stewardship Program Support System (WASPSS) platform
[10, 29] is a CDSS focused on ASPs and infectious disease management. It was
developed by the University of Murcia in collaboration with UHG at the same time
as the PAMACTA team was created, which provided the opportunity to focus on
the current needs of an ASP team starting from scratch. WASPSS is currently in the
production stage and it is used daily by the PAMACTA team. Furthermore, it is
being piloted in other seven public hospitals in Spain.
4. System architecture overview
An overview of the WASPSS software architecture is shown in Figure 1. The
system is capable of obtaining information from multiple hospital information
systems, which is a key factor to provide a proper support to the ASP team. The
hospital systems and some examples of data collected byWASPSS are the following:
• Pharmacy systems: the dispensations or administrations of antimicrobials
• Microbiology laboratory: the results of cultures, the microorganisms found,
and the resistances or susceptibilities found in the laboratory
• Clinical tests laboratory: white-cell count, creatinine levels and other infection-
related tests
• Electronic health records (EHR): data related to patient, such as previous stays,
current ward, and stays at ICU.
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To perform data integration, a Health Level 7 (HL7) interface engine has been
included. HL7 is a widely accepted set of standards for interoperability between
health care organizations. HL7 provides messaging for exchanging, sharing and
retrieving electronic health information between medical applications in near real
time. Most HIS vendors adhere to these standards when developing application
interfaces to exchange patient data. Additionally, WASPSS also supports the batch-
loading of data files for those cases in which the HL7 interface is not available.
Furthermore, a Java Message Service server is also used for the communication
between WASPSS modules.
The data collected from hospital systems are filtered, structured and stored into
an operational database by using extract-transform-load processes. This database
acts as a centralized data hub for all the WASPSS modules.
WASPSS uses artificial intelligence techniques to provide proper support for ASP
teams. In particular,WASPSS includes a knowledgemodule to incorporate clinical
literature and daily practice knowledge [33, 37, 42]. To this end, themodule imple-
ments a rule-based reasoning architecture composed of a knowledge base and a rule-
based engine. The knowledge base contains production rules, ontologies and other
business processmodels relatedwith antimicrobial stewardship. The rule-based engine
can make use of both the knowledge base and the data collected from the hospital to
perform abstractions, raise alerts or evaluate processes, and its results can be stored
back into the database or communicated through JMS to the otherWASPSS modules.
Finally, the system includes a web-based interface that offers a different front-
end for each user role of the ASP team, facilitating its usage for each clinician
involved with antimicrobial stewardship within the institution. In the next sections,
we describe in detail the capabilities of WASPSS to provide decision support for
tasks related with both particular patients and the whole clinical organization.
5. Patient-centered decision support
The capability of WASPSS to aggregate information from different hospital
systems allows to provide comprehensive decision support for a particular patient.
This is especially useful in antibiotic prescription and patient-related alerts, as
explained next.
Figure 1.
Overview of the WASPSS platform and its different modules.
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5.1 Antibiotic prescription
The selection of the most appropriate antibiotic treatment is a key decision both
to improve the patient’s health and to reduce the risk of antimicrobial resistance for
the community. However, it usually occurs that the microorganism responsible for
the infection has not yet been determined when the clinician must decide the
antibiotic therapy to use. In these situations, clinicians must use all the available
information about the patient and the infection (possible focus, previous infections,
etc.) along with the information regarding the common pathogens found in the
hospital and their resistance patterns, which is called the local cumulative
antibiogram. After deciding this initial therapy, known as empiric therapy, clinicians
can adjust, suspend or incorporate antibiotics when the infecting microorganism is
found and analyzed, starting then a targeted therapy. However, the development of a
local cumulative antibiogram is a time-consuming task that requires gathering
information about the microorganisms found within the institution, and therefore,
it is usually generated yearly.
The antibiotic prescription module of WASPSS assists physicians in the prescrip-
tion of appropriate empiric or targeted antibiotic treatments (Figure 2). Thanks to
the data collected from the microbiology system, WASPSS can calculate the cumu-
lative antibiograms instantly. Furthermore, it can use data from any period and
stratify them attending to different criteria in order to obtain, for example, the most
effective antibiotic for blood infections in the ICU ward during the last year.
The efficacy of each antibiotic is computed under those criteria, from 1 (less
effective) to 100 (fully effective), based on the number needed to fail measure [30].
Finally, a list with the available antibiotics ranked by efficacy and confidence
interval is proposed to the physician. The tool shows additional notes about each
option, such as whether a restricted use of the antibiotic is recommended or if it can
be administered orally. Furthermore, the tool can present the list of most common
microorganisms found under the search criteria, along with their susceptibilities to
antimicrobials. A graphical view of the results is also available through a bipartite
model, which represents the relationships between microorganisms and antibiotics
by means of channels of different width [31]. With these tools, physicians can take
a more informed decision related with both empiric and targeted antimicrobial
therapies.
5.2 Alerts, recommendations and assessment of infections
One of the common decision support tasks from CDSSs is to alert clinicians
when certain events occur. In case of the antimicrobial stewardship scenario, typical
alerts are related with the detection of bacteria resistant to multiple antibiotics, the
results of tests that indicate severe infections, the prescription of restricted antibi-
otics or the opportunities to change the route of administration of an antibiotic to a
less aggressive route for a patient.
WASPSS includes a pre-defined set of these alerts in the form of production
rules within its knowledge base. Furthermore, as shown in Figure 3, clinicians may
use the web-based interface to perform detailed queries that can also be stored as
new alerts. If that is the case, the query is translated into production rules, stored in
the knowledge base and executed daily. Each new case found will be notified then
as any other alert automatically.
One recurrent problem is CDSSs is the alarm fatigue, that is, users tend to ignore
all alerts when too many of them are launched [32]. In order to cope with this
problem, WASPSS allows to define alerts with three different levels of severity.
Furthermore, alerts can be restricted to specific user profiles. By this way, each user
6
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Figure 2.
Screenshot of the antibiotic prescription module. Given a search criteria, a rank of most effective antimicrobials
is provided based on the local cumulative antibiogram (a). A graphical bipartite model is also available in
order to show relationships between antibiotics and microorganisms (b). The antimicrobial efficacy data shown
in this picture are fictitious.
7
WASPSS: A Clinical Decision Support System for Antimicrobial Stewardship
DOI: http://dx.doi.org/10.5772/intechopen.91648
receives only those alerts relevant to their role in the ASP team, and they can decide
whether to revise only those with higher severity or all of them.
To manage each particular alert, WASPSS displays a patient-centered timeline
view (Figure 4). This view provides a temporal perspective of all the data recov-
ered from hospital systems that are related with antimicrobial stewardship, such as
treatments, cultures, clinical tests and stays in wards. When an alert is fired, it is
linked with the clinical events that caused it and they are highlighted in this view.
By this way, the ASP team can evaluate all the relevant data regarding a patient
when deciding which clinical action must be made in response to each alert.
Most of the clinical actions undertaken by the ASP team consist of performing
recommendations to the physician staff related to changes in the antibiotic therapy
of a particular patient, or to suggest cultures or other clinical tests whose results can
improve the treatment of an infection. WASPSS allows the ASP team to create those
recommendations for a specific patient, attaching their reasons and the suggested
actions. Physicians can then access these recommendations by using the WASPSS
platform. Optionally, these recommendations can be sent through the HL7 interface
to other systems in order to facilitate the daily hospital workflow.
Alerts can also generate automatically informed recommendations that only
need to be validated by the ASP team in order to be communicated. For example,
WASPSS can detect that an antibiotic that is being administered by the intravenous
route for many days can also be administered orally, which is less aggressive for the
Figure 3.
Screenshot of the alerts module. Clinicians can build detailed queries with a user-friendly interface. Those
queries considered as relevant can be automatically translated into production rules and stored as new alerts in
the knowledge base.
8
Advances in Intelligent and Personalized Clinical Decision Support Systems
patient. Then, an alert is raised with a recommendation completed by the system,
which includes the antibiotic, the suggestion of changing its administration route,
and also the conditions that must be checked before undertaking this action, such
as that the patient has no digestive problems that contraindicate the ingest
of antibiotics.
WASPSS also facilitates the assessment of the infection for a particular patient.
The patient-centered view includes the relevant data obtained from the EHR, along
with the results from the microbiology tests and the rest of the clinical tests
performed to the patient. The visualization of all these data in a clear and organized
way facilitates the evaluation of the patient’s infection by clinicians.
6. Institutional decision support
Along with the patient-centered perspective, a broader vision is required in
order to perform a proper antimicrobial stewardship within the institution. The
monitoring of both clinical and process outcomes is important for proposing new
strategic actions, and also for removing measures or policies that are not having any
real impact on patient safety, economy or antibiotic resistance.
Global surveillance and monitoring in WASPSS is achieved by four modules.
First, the epidemiology module (Figure 5a) visualizes the evolution of statistical
measures such as prevalence and incidence of microorganisms, antibiotics, micro-
biological sample types and alerts.
Second, the dashboarding module (Figure 5b) provides interactive charts that
summarize global measures related to antibiograms, alerts and ASP recommenda-
tions over a specified time interval.
Figure 4.
Screenshot of the timeline view with the details of the alert and all the patient’s clinical events. The patient’s
data shown in this picture are fictitious.
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Third, actionable reports are generated using the reporting module (Figure 6a).
Currently, two kinds of parameterized reports are available: the first one lists
all the antibiotics and microbiological tests of hospitalized patients during a
specified period of time, grouped by department and sorted by bed number; the
second one includes statistical information (prevalence, incidence, etc.) about all
the microorganisms, antibiotics, sample types and alerts occurred over a specified
time interval.
Last, the ASP indicator module computes several process indicators (Figure 6b)
whose results are presented in two forms: (i) as a run chart showing the evolution of
Figure 5.
Global surveillance support in WASPSS: (a) epidemiology and (b) dashboarding modules. The data shown in
this picture are fictitious.
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the indicator over time and (ii) as a control table showing results of the current
month and year, labeled with color codes indicating the goodness of the result.
7. Incorporation of clinical knowledge
WASPSS is also designed to incorporate different kinds of knowledge related
with antimicrobial resistance [33].
Figure 6.
Global surveillance support in WASPSS: (a) reporting and (b) ASP indicator modules. The data shown in this
picture are fictitious.
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The main source for the knowledge included is the expert rules from the
EUropean Committee on Antimicrobial Susceptibility Testing (EUCAST) [34, 35].
These rules include the antibiotics to which each bacterial species is intrinsically
resistant, those resistant patterns that are considered as exceptional and that should
be re-checked to discard any problem on the laboratory tests, and resistance pat-
terns that can be inferred from others found in laboratory.
WASPSS combines production rules with ontologies in order to incorporate the
EUCAST rules in its knowledge base. Production rules are used to model most of the
EUCAST knowledge, while ontologies are needed to model the hierarchical rela-
tionships of antibiotics and bacteria [36, 37].
This knowledge can be useful for many tasks such as the detection of
incoherencies in laboratory results (e.g., bacteria that are found susceptible to an
antibiotic to which they should be intrinsically resistant according to the EUCAST
rules) and the detection of possible therapy failure because the infecting agent is
found as resistant to all the antibiotics currently administered to the patient. In this
last example, this knowledge has proved to be useful for increasing the number of
cases detected and their clinical relevance [38].
8. Experimental features
The knowledge base and the inference engine provide opportunities for further
knowledge-based expansions, incorporating knowledge from different sources. One
of these sources can be the Clinical Practice Guidelines (CPGs), that is, widely
accepted recommendations, processes and decision steps based on clinical evidence
focused on improving the assistance of patients [39, 40]. Despite the fact that the
use of CPGs has proved to improve clinical outcomes, they must be adapted to the
particularities of each individual patient, which sometimes present a cumbersome
problem for they use in daily practice [41].
WASPSS includes an experimental module to facilitate the visualization, adop-
tion and evaluation of guidelines related with antimicrobial stewardship, focusing
on the processes and decisions included in the guideline and those tasks that can be
monitored thanks to the information gathered by the system [42]. An example of
the graphical interface of this module is shown in Figure 7. The processes included
in the guideline must be modeled by using the Business Process Model Notation
(BPMN) and the decision-related recommendations by using the Decision Model
Notation (DMN). These models are stored within the knowledge base and can be
used to graphically visualize the tasks and decisions contained in the guideline.
Production rules are then used to evaluate the status of each relevant task of the
guideline and provide an estimation of the tasks already finished, those on-going
and also those that may have been omitted. Finally, in combination with the
patient-centered timeline view, the next guideline tasks can be scheduled in a
flexible way, allowing the adaptation of the guideline to the particularities of each
patient.
Another experimental extension is the incorporation of prediction models
within the knowledge base. WASPSS includes an experimental clinical prediction
rules module that is capable of incorporating prediction models based on logistic
regression and evaluating them for a particular patient. Logistic regression is one
of the most used techniques for developing models in clinical practice and can
be combined with other techniques to deal with common problems related with
data mining in antimicrobial resistance, such as unbalanced datasets or concept
drift [43].
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9. Future work
When dealing with clinical data, it is usual to find uncertainties in test results,
clinical guidelines or prediction models, especially due to missing patient data. As a
future research line, we plan to detect these uncertainties as well as the data required to
solve themwhen possible. Then, these data will be asked to the user and incorporated
into the knowledge base to improve the results of the differentWASPSSmodules.
We consider that a grounded explanation of a recommendation is one of the key
factors for the success of a CDSS. The methods and models used in WASPSS
(production rules, ontologies, etc.) allow the traceability of any alert, decision or
abstraction. Following this idea, we are studying the incorporation of explainable
machine learning methods to improve the justifications of the results of the
prediction models.
The use of WASPSS in several hospitals offers us the opportunity to combine
efforts among different ASP teams to improve the global outcomes in antimicrobial
stewardship. On the other hand, it raises the problems of the interchange of knowl-
edge among hospitals [37] and the need for dealing with a huge amount of data,
which may require the adaptation of WASPSS to a big data environment [44].
Other future changes may be taken into consideration as new technologies are
adopted by the hospitals using WASPSS. For example, the Fast Healthcare Interop-
erability Resources (FHIR) protocol has become very popular in last years and its
incorporation into WASPSS may be considered in the medium term.
10. Conclusions
CDSSs have been widely used to assist physicians when dealing with infectious
diseases. However, the need for coordinated efforts against the rise of antimicrobial
resistance urges them to provide new functionalities.
Figure 7.
Graphical interface for the CPG experimental module of WASPSS. The patient’s data shown in this picture are
fictitious.
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WASPSS is our proposal for a CDSS focused on the assistance of ASP teams in
the hospital environment. It combines techniques from business intelligence and
artificial intelligence to provide an integrated perspective for antimicrobial stew-
ardship.
On the one hand, WASPSS collects data from multiple hospital information
systems and incorporates knowledge in the form of alerts and expert EUCAST rules.
It is also capable of incorporating knowledge from CPGs and prediction models
related with antimicrobial resistance.
On the other hand, WASPSS provides alerts and functionalities for antibiotic
prescription, ASP recommendations and infection assessment through a patient-
centered view in order to assist physicians when taking decisions concerning a
particular patient, and global surveillance modules to provide support for strategic
decisions related with epidemiology, global clinical outcomes and reporting.
In conclusion and according to our experience with WASPSS, a multi-user
perspective, capabilities to integrate data and knowledge from different sources,
and both patient-centered and institutional perspectives are key requisites for any
CDSS focused on antimicrobial stewardship.
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